Why Cannabis Fits Your Biology — and Why Alcohol Doesn't

The difference between how cannabis and alcohol interact with the human body highlights an evolutionary contrast. The human body possesses an entire, highly sophisticated physiological system specifically built to produce and process cannabinoid molecules. Alcohol, on the other hand, has no biological home in our system. It is a foreign chemical intruder that achieves its effects by broadly altering cellular structures and hijacking general neurotransmitter networks. [Lu & Mackie (2016, Biological Psychiatry)]

The Endocannabinoid System: Your Internal Regulatory Network

The human body naturally produces its own cannabinoids, known as endocannabinoids — lipid-based signalling molecules manufactured within our tissues. These molecules are the foundational components of the endocannabinoid system (ECS), a master regulatory network distributed throughout the brain, central nervous system, immune system, and major organs. [Devane et al. (1992, Science)]

The sole purpose of the ECS is to maintain homeostasis — the optimal biological balance required for survival. When stress, pain, inflammation, or anxiety throws a biological pathway out of alignment, the ECS acts as a dimmer switch to bring the system back to baseline. [Devane et al. (1992)]

The Two Primary Endocannabinoids

Anandamide (AEA): Derived from the Sanskrit word ananda (“bliss”), anandamide is a fragile, short-lived molecule. It is synthesised on demand by the body to regulate mood, fear extinction, appetite, and pain perception. Within seconds of release, it is broken down by the enzyme fatty acid amide hydrolase (FAAH), preventing prolonged sedation. [Mechoulam & Parker (2013, Annual Review of Psychology)]

2-Arachidonoylglycerol (2-AG): The most abundant endocannabinoid in the brain, 2-AG plays a critical role in managing immune responses, reducing inflammation, and protecting neurons from overexcitation. Unlike anandamide, which is a partial agonist at CB₁, 2-AG is a full agonist and is present at concentrations roughly 200 times higher than anandamide in brain tissue. [Pacher et al. (2006, Pharmacological Reviews)]

Retrograde Signalling: How the ECS Works

Virtually all standard neurotransmitters — serotonin, dopamine, adrenaline — travel anterogradely: fired from a sending neuron (presynaptic) across the synaptic gap to a receiving neuron (postsynaptic). Endocannabinoids operate in reverse through retrograde signalling. [Wilson & Nicoll (2001, Nature)]

When a postsynaptic neuron becomes overstimulated — firing too many anxiety or pain signals — it synthesises endocannabinoids on demand. These molecules travel backwards across the synaptic cleft and bind to CB₁ or CB₂ receptors on the sending neuron. This signals the sending neuron to turn down the volume, instantly halting the excessive release of excitatory neurotransmitters. It is a negative feedback loop built directly into the architecture of the nervous system. [Wilson & Nicoll (2001)]

How Cannabis Plugs Into This Network

Medical cannabis is effective because the plant's active compounds — phytocannabinoids — share a strikingly similar three-dimensional molecular geometry to the endocannabinoids our bodies naturally produce.

THC: The Anandamide Copycat. Δ⁹-tetrahydrocannabinol (THC) is a structural analogue of anandamide. It acts as an exogenous key that fits into the exact same CB₁ and CB₂ receptor locks that your body built for its own internal bliss molecule. The critical difference lies in metabolic longevity: your body breaks down its own anandamide within seconds using FAAH, but plant-derived THC is immune to this enzyme. THC is metabolised primarily by cytochrome P450 enzymes in the liver, allowing it to bind to receptors for hours — providing a sustained, amplified version of the body's natural stress-relief mechanism. [Mechoulam & Parker (2013)]

CBD: Preserving Your Natural Supply. Cannabidiol (CBD) does not directly bind to CB₁ receptors with high affinity the way THC does. Instead, one of its key mechanisms is the inhibition of the FAAH enzyme, reducing the breakdown of the body's own anandamide. This allows your natural “bliss molecule” to circulate longer, providing anxiolysis through your endogenous system rather than through direct receptor activation. [Bisogno et al. (2001, British Journal of Pharmacology)]

The Alcohol Contrast: A Toxin With No Native Home

There is no such thing as an “endo-alcohol system.” The human body does not synthesise internal ethanol to manage mood, and we have zero biological receptors designed to receive it. Alcohol is classified pharmacologically as a xenobiotic — a foreign chemical substance entirely alien to the body's regulatory architecture. [Harris et al. (2008, Science Signaling)]

Because alcohol cannot cleanly unlock a specific, evolutionarily tailored regulatory receptor, it achieves its effects through non-specific brute force. Ethanol is a tiny, highly water- and fat-soluble molecule that easily passes through the blood-brain barrier and works by dissolving into the lipid bilayers of cell membranes throughout the brain.

Once inside cell membranes, alcohol physically alters their fluid dynamics and squeezes into the hydrophobic pockets of ligand-gated ion channels. It forces GABA_A receptors to stay open, causing a mass influx of chloride ions that globally depresses CNS electrical activity. Simultaneously, it physically blocks NMDA glutamate receptors, turning off the brain's baseline alert system. Because this action is completely unlocalised, alcohol cannot selectively target an overactive anxiety pathway without also depressing the entire surrounding neurological architecture. [Harris et al. (2008)]

Key Pharmacological Comparison

The Core Takeaway

Medical cannabis functions as an exogenous supplement to an existing, evolutionarily refined biological network designed to stabilise human mood and stress. It interfaces with a system that already produces and regulates cannabinoid molecules — a system that has been part of vertebrate biology for over 500 million years. [Lu & Mackie (2016)]

Alcohol is a structural disruptor that forces the nervous system into sedation by altering cell architecture, exacting a steep biological debt to clean up the chemical fallout. It has no dedicated receptor system, no endogenous analogue, and no regulatory pathway. It simply breaks things until the system slows down.

For a deeper exploration of how these mechanisms translate into real-world outcomes, see how alcohol and cannabis affect the brain, why alcohol fails as an anxiolytic, and the full Harm Matrix.

Sources: [Devane et al. (1992, Science)] | [Wilson & Nicoll (2001, Nature)] | [Bisogno et al. (2001, British Journal of Pharmacology)] | [Pacher et al. (2006, Pharmacological Reviews)] | [Harris et al. (2008, Science Signaling)] | [Mechoulam & Parker (2013, Annual Review of Psychology)] | [Lu & Mackie (2016, Biological Psychiatry)]